<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<html>
 <body>
  <pubmedarticleset>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32219356
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       31
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        2380-6591
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
         <day>
          27
         </day>
        </pubdate>
       </journalissue>
       <title>
        JAMA cardiology
       </title>
       <isoabbreviation>
        JAMA Cardiol
       </isoabbreviation>
      </journal>
      <articletitle>
       Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.1001/jamacardio.2020.1017
      </elocationid>
      <abstract>
       <abstracttext label="Importance" nlmcategory="UNASSIGNED">
        Increasing numbers of confirmed cases and mortality rates of coronavirus disease 2019 (COVID-19) are occurring in several countries and continents. Information regarding the impact of cardiovascular complication on fatal outcome is scarce.
       </abstracttext>
       <abstracttext label="Objective" nlmcategory="UNASSIGNED">
        To evaluate the association of underlying cardiovascular disease (CVD) and myocardial injury with fatal outcomes in patients with COVID-19.
       </abstracttext>
       <abstracttext label="Design, Setting, and Participants" nlmcategory="UNASSIGNED">
        This retrospective single-center case series analyzed patients with COVID-19 at the Seventh Hospital of Wuhan City, China, from January 23, 2020, to February 23, 2020. Analysis began February 25, 2020.
       </abstracttext>
       <abstracttext label="Main Outcomes and Measures" nlmcategory="UNASSIGNED">
        Demographic data, laboratory findings, comorbidities, and treatments were collected and analyzed in patients with and without elevation of troponin T (TnT) levels.
       </abstracttext>
       <abstracttext label="Result" nlmcategory="UNASSIGNED">
        Among 187 patients with confirmed COVID-19, 144 patients (77%) were discharged and 43 patients (23%) died. The mean (SD) age was 58.50 (14.66) years. Overall, 66 (35.3%) had underlying CVD including hypertension, coronary heart disease, and cardiomyopathy, and 52 (27.8%) exhibited myocardial injury as indicated by elevated TnT levels. The mortality during hospitalization was 7.62% (8 of 105) for patients without underlying CVD and normal TnT levels, 13.33% (4 of 30) for those with underlying CVD and normal TnT levels, 37.50% (6 of 16) for those without underlying CVD but elevated TnT levels, and 69.44% (25 of 36) for those with underlying CVD and elevated TnTs. Patients with underlying CVD were more likely to exhibit elevation of TnT levels compared with the patients without CVD (36 [54.5%] vs 16 [13.2%]). Plasma TnT levels demonstrated a high and significantly positive linear correlation with plasma high-sensitivity C-reactive protein levels (β = 0.530, P &lt; .001) and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels (β = 0.613, P &lt; .001). Plasma TnT and NT-proBNP levels during hospitalization (median [interquartile range (IQR)], 0.307 [0.094-0.600]; 1902.00 [728.35-8100.00]) and impending death (median [IQR], 0.141 [0.058-0.860]; 5375 [1179.50-25695.25]) increased significantly compared with admission values (median [IQR], 0.0355 [0.015-0.102]; 796.90 [401.93-1742.25]) in patients who died (P = .001; P &lt; .001), while no significant dynamic changes of TnT (median [IQR], 0.010 [0.007-0.019]; 0.013 [0.007-0.022]; 0.011 [0.007-0.016]) and NT-proBNP (median [IQR], 352.20 [174.70-636.70]; 433.80 [155.80-1272.60]; 145.40 [63.4-526.50]) was observed in survivors (P = .96; P = .16). During hospitalization, patients with elevated TnT levels had more frequent malignant arrhythmias, and the use of glucocorticoid therapy (37 [71.2%] vs 69 [51.1%]) and mechanical ventilation (41 [59.6%] vs 14 [10.4%]) were higher compared with patients with normal TnT levels. The mortality rates of patients with and without use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers was 36.8% (7 of 19) and 25.6% (43 of 168).
       </abstracttext>
       <abstracttext label="Conclusions and Relevance" nlmcategory="UNASSIGNED">
        Myocardial injury is significantly associated with fatal outcome of COVID-19, while the prognosis of patients with underlying CVD but without myocardial injury is relatively favorable. Myocardial injury is associated with cardiac dysfunction and arrhythmias. Inflammation may be a potential mechanism for myocardial injury. Aggressive treatment may be considered for patients at high risk of myocardial injury.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Guo
        </lastname>
        <forename>
         Tao
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Fan
        </lastname>
        <forename>
         Yongzhen
        </forename>
        <initials>
         Y
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chen
        </lastname>
        <forename>
         Ming
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wu
        </lastname>
        <forename>
         Xiaoyan
        </forename>
        <initials>
         X
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Zhang
        </lastname>
        <forename>
         Lin
        </forename>
        <initials>
         L
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         He
        </lastname>
        <forename>
         Tao
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Hairong
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wan
        </lastname>
        <forename>
         Jing
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Xinghuan
        </forename>
        <initials>
         X
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lu
        </lastname>
        <forename>
         Zhibing
        </forename>
        <initials>
         Z
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        27
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       JAMA Cardiol
      </medlineta>
      <nlmuniqueid>
       101676033
      </nlmuniqueid>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        29
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        29
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        29
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32219356
      </articleid>
      <articleid idtype="pii">
       2763845
      </articleid>
      <articleid idtype="doi">
       10.1001/jamacardio.2020.1017
      </articleid>
      <articleid idtype="pmc">
       PMC7101506
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Proc (Bayl Univ Med Cent). 2018 Oct 26;31(4):419-423
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30948970
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2020 Feb 20;382(8):727-733
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31978945
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Med Virol. 2020 Apr;92(4):401-402
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31950516
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2013 Nov 27;310(20):2191-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24141714
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Feb 7;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32031570
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2012 Jun 20;307(23):2526-33
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22797452
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):497-506
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986264
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci China Life Sci. 2020 Mar;63(3):457-460
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32009228
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Med. 2005 Aug;11(8):875-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16007097
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Eur J Clin Invest. 2009 Jul;39(7):618-25
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19453650
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Feb 24;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32091533
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Int J Infect Dis. 2020 Feb;91:264-266
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31953166
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Jan 23;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31971553
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32228309
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       01
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1524-4539
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
         <day>
          31
         </day>
        </pubdate>
       </journalissue>
       <title>
        Circulation
       </title>
       <isoabbreviation>
        Circulation
       </isoabbreviation>
      </journal>
      <articletitle>
       Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.1161/CIRCULATIONAHA.120.047063
      </elocationid>
      <abstract>
       <abstracttext>
        Covid-19 is a global pandemic that is wreaking havoc with the health and economy of much of human civilization. Electrophysiologists have been impacted personally and professionally by this global catastrophe. In this joint document from representatives of the HRS, ACC and AHA we identify the potential risks of exposure to patients, allied health care staff, industry representatives and hospital administrators. We describe the impact of COVID-19 on cardiac arrhythmias and methods of triage based on acuity and patient comorbidities. We provide guidance for managing invasive and non-invasive electrophysiology procedures, clinic visits and cardiac device interrogations. We discuss resource conservation and the role of tele-medicine in remote patient care along with management strategies for affected patients.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Lakkireddy
        </lastname>
        <forename>
         Dhanunjaya R
        </forename>
        <initials>
         DR
        </initials>
        <affiliationinfo>
         <affiliation>
          The Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, KS.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chung
        </lastname>
        <forename>
         Mina K
        </forename>
        <initials>
         MK
        </initials>
        <affiliationinfo>
         <affiliation>
          Heart, Vascular, and Thoracic Institute and Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gopinathannair
        </lastname>
        <forename>
         Rakesh
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          The Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, KS.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Patton
        </lastname>
        <forename>
         Kristen K
        </forename>
        <initials>
         KK
        </initials>
        <affiliationinfo>
         <affiliation>
          University of Washington, Seattle, WA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gluckman
        </lastname>
        <forename>
         Ty J
        </forename>
        <initials>
         TJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Turagam
        </lastname>
        <forename>
         Mohit
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Mt. Sinai School of Medicine, New York, NY.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cheung
        </lastname>
        <forename>
         Jim
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Weill Cornell School of Medicine, New York, NY.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Patel
        </lastname>
        <forename>
         Parin
        </forename>
        <initials>
         P
        </initials>
        <affiliationinfo>
         <affiliation>
          Ascension Health System, Indianapolis, IN.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sotomonte
        </lastname>
        <forename>
         Jaun
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Centro Cardiovascular, San Juan, PR.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lampert
        </lastname>
        <forename>
         Rachel
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Yale School of Medicine, Hartford, CT.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Han
        </lastname>
        <forename>
         Janet K
        </forename>
        <initials>
         JK
        </initials>
        <affiliationinfo>
         <affiliation>
          VA Greater Los Angeles Healthcare System and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Rajagopalan
        </lastname>
        <forename>
         Bharath
        </forename>
        <initials>
         B
        </initials>
        <affiliationinfo>
         <affiliation>
          Prairie Heart Institute, Springfield, IL.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Eckhardt
        </lastname>
        <forename>
         Lee
        </forename>
        <initials>
         L
        </initials>
        <affiliationinfo>
         <affiliation>
          University of Wisconsin, Madison, WI.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Joglar
        </lastname>
        <forename>
         Jose
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          UT Southwestern, Dallas, TX.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sandau
        </lastname>
        <forename>
         Kristin
        </forename>
        <initials>
         K
        </initials>
        <affiliationinfo>
         <affiliation>
          Bethel University, St. Paul, MN.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Olshansky
        </lastname>
        <forename>
         Brian
        </forename>
        <initials>
         B
        </initials>
        <affiliationinfo>
         <affiliation>
          Mason City Clinic, Mason City, IA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wan
        </lastname>
        <forename>
         Elaine
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          Columbia University Medical Center, New York, NY.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Noseworthy
        </lastname>
        <forename>
         Peter A
        </forename>
        <initials>
         PA
        </initials>
        <affiliationinfo>
         <affiliation>
          Mayo Clinic, Rochester, MN.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Leal
        </lastname>
        <forename>
         Miguel
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          University of Wisconsin, Madison, WI.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Kaufman
        </lastname>
        <forename>
         Elizabeth
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          Metro Health Medical Center, Cleveland, OH.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gutierrez
        </lastname>
        <forename>
         Alejandra
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          University of Minnesota School of Medicine, Minneapolis, MN.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Marine
        </lastname>
        <forename>
         Joseph M
        </forename>
        <initials>
         JM
        </initials>
        <affiliationinfo>
         <affiliation>
          Johns Hopkins School of Medicine, Baltimore, MD.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Paul J
        </forename>
        <initials>
         PJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Stanford University, Palo Alto, CA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Russo
        </lastname>
        <forename>
         Andrea M
        </forename>
        <initials>
         AM
        </initials>
        <affiliationinfo>
         <affiliation>
          Cooper Medical School of Rowan University, Camden, NJ.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        31
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Circulation
      </medlineta>
      <nlmuniqueid>
       0147763
      </nlmuniqueid>
      <issnlinking>
       0009-7322
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      AIM
     </citationsubset>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       Pandemic
      </keyword>
      <keyword majortopicyn="N">
       Practice
      </keyword>
      <keyword majortopicyn="N">
       Recommendations
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        2
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        2
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        2
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32228309
      </articleid>
      <articleid idtype="doi">
       10.1161/CIRCULATIONAHA.120.047063
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32247013
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       07
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1556-3871
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          01
         </day>
        </pubdate>
       </journalissue>
       <title>
        Heart rhythm
       </title>
       <isoabbreviation>
        Heart Rhythm
       </isoabbreviation>
      </journal>
      <articletitle>
       Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       S1547-5271(20)30289-7
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.hrthm.2020.03.028
      </elocationid>
      <abstract>
       <abstracttext>
        Covid-19 is a global pandemic that is wreaking havoc with the health and economy of much of human civilization. Electrophysiologists have been impacted personally and professionally by this global catastrophe. In this joint document from representatives of the HRS, ACC and AHA we identify the potential risks of exposure to patients, allied health care staff, industry representatives and hospital administrators. We describe the impact of COVID-19 on cardiac arrhythmias and methods of triage based on acuity and patient comorbidities. We provide guidance for managing invasive and non-invasive electrophysiology procedures, clinic visits and cardiac device interrogations. We discuss resource conservation and the role of tele-medicine in remote patient care along with management strategies for affected patients.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2020. Published by Elsevier Inc.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Lakkireddy
        </lastname>
        <forename>
         Dhanunjaya R
        </forename>
        <initials>
         DR
        </initials>
        <affiliationinfo>
         <affiliation>
          The Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, KS. Electronic address: dhanunjaya.lakkireddy@hcahealthcare.com.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chung
        </lastname>
        <forename>
         Mina K
        </forename>
        <initials>
         MK
        </initials>
        <affiliationinfo>
         <affiliation>
          Heart, Vascular, and Thoracic Institute and Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gopinathannair
        </lastname>
        <forename>
         Rakesh
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          The Kansas City Heart Rhythm Institute &amp; Research Foundation, Overland Park, KS.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Patton
        </lastname>
        <forename>
         Kristen K
        </forename>
        <initials>
         KK
        </initials>
        <affiliationinfo>
         <affiliation>
          University of Washington, Seattle, WA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gluckman
        </lastname>
        <forename>
         Ty J
        </forename>
        <initials>
         TJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Turagam
        </lastname>
        <forename>
         Mohit
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Mt. Sinai School of Medicine, New York, NY.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cheung
        </lastname>
        <forename>
         Jim
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Weill Cornell School of Medicine, New York, NY.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Patel
        </lastname>
        <forename>
         Parin
        </forename>
        <initials>
         P
        </initials>
        <affiliationinfo>
         <affiliation>
          Ascension Health System, Indianapolis, IN.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sotomonte
        </lastname>
        <forename>
         Juan
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Centro Cardiovascular, San Juan, PR.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lampert
        </lastname>
        <forename>
         Rachel
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Yale School of Medicine, Hartford, CT.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Han
        </lastname>
        <forename>
         Janet K
        </forename>
        <initials>
         JK
        </initials>
        <affiliationinfo>
         <affiliation>
          VA Greater Los Angeles Healthcare System and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Rajagopalan
        </lastname>
        <forename>
         Bharath
        </forename>
        <initials>
         B
        </initials>
        <affiliationinfo>
         <affiliation>
          Prairie Heart Institute, Springfield, IL.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Eckhardt
        </lastname>
        <forename>
         Lee
        </forename>
        <initials>
         L
        </initials>
        <affiliationinfo>
         <affiliation>
          University of Wisconsin, Madison, WI.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Joglar
        </lastname>
        <forename>
         Jose
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          UT Southwestern, Dallas, TX.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sandau
        </lastname>
        <forename>
         Kristin
        </forename>
        <initials>
         K
        </initials>
        <affiliationinfo>
         <affiliation>
          Bethel University, St. Paul, MN.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Olshansky
        </lastname>
        <forename>
         Brian
        </forename>
        <initials>
         B
        </initials>
        <affiliationinfo>
         <affiliation>
          Mason City Clinic, Mason City, IA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wan
        </lastname>
        <forename>
         Elaine
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          Columbia University Medical Center, New York, NY.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Noseworthy
        </lastname>
        <forename>
         Peter A
        </forename>
        <initials>
         PA
        </initials>
        <affiliationinfo>
         <affiliation>
          Mayo Clinic, Rochester, MN.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Leal
        </lastname>
        <forename>
         Miguel
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          University of Wisconsin, Madison, WI.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Kaufman
        </lastname>
        <forename>
         Elizabeth
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          Metro Health Medical Center, Cleveland, OH.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gutierrez
        </lastname>
        <forename>
         Alejandra
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          University of Minnesota School of Medicine, Minneapolis, MN.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Marine
        </lastname>
        <forename>
         Joseph M
        </forename>
        <initials>
         JM
        </initials>
        <affiliationinfo>
         <affiliation>
          Johns Hopkins School of Medicine, Baltimore, MD.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Paul J
        </forename>
        <initials>
         PJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Stanford University, Palo Alto, CA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Russo
        </lastname>
        <forename>
         Andrea M
        </forename>
        <initials>
         AM
        </initials>
        <affiliationinfo>
         <affiliation>
          Cooper Medical School of Rowan University, Camden, NJ.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D017065">
        Practice Guideline
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        01
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Heart Rhythm
      </medlineta>
      <nlmuniqueid>
       101200317
      </nlmuniqueid>
      <issnlinking>
       1547-5271
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       electrophysiology
      </keyword>
      <keyword majortopicyn="N">
       pandemic
      </keyword>
      <keyword majortopicyn="N">
       pathology
      </keyword>
      <keyword majortopicyn="N">
       practice
      </keyword>
      <keyword majortopicyn="N">
       recommendations
      </keyword>
      <keyword majortopicyn="N">
       virus
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        25
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        25
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32247013
      </articleid>
      <articleid idtype="pii">
       S1547-5271(20)30289-7
      </articleid>
      <articleid idtype="doi">
       10.1016/j.hrthm.2020.03.028
      </articleid>
      <articleid idtype="pmc">
       PMC7118697
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Eur J Pharmacol. 2004 Jan 19;484(1):41-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14729380
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Mar 28;395(10229):1054-1062
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32171076
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        BMC Med. 2018 Nov 7;16(1):200
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30400791
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2020 Mar 5;382(10):929-936
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32004427
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ann Rheum Dis. 2001 Mar;60(3):301
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         11245140
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2020 Mar 19;382(12):1177-1179
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32074444
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Heart Rhythm. 2015 Jul;12(7):e69-100
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25981148
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Toxicol Clin Toxicol. 1995;33(4):369-70
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         7629906
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32247212
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       19
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1878-0334
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         14
        </volume>
        <issue>
         3
        </issue>
        <pubdate>
         <medlinedate>
          2020 May - Jun
         </medlinedate>
        </pubdate>
       </journalissue>
       <title>
        Diabetes &amp; metabolic syndrome
       </title>
       <isoabbreviation>
        Diabetes Metab Syndr
       </isoabbreviation>
      </journal>
      <articletitle>
       Cardiovascular disease and COVID-19.
      </articletitle>
      <pagination>
       <medlinepgn>
        247-250
       </medlinepgn>
      </pagination>
      <elocationid eidtype="pii" validyn="Y">
       S1871-4021(20)30053-9
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.dsx.2020.03.013
      </elocationid>
      <abstract>
       <abstracttext label="BACKGROUND AND AIMS" nlmcategory="OBJECTIVE">
        Many patients with coronavirus disease 2019 (COVID-19) have underlying cardiovascular (CV) disease or develop acute cardiac injury during the course of the illness. Adequate understanding of the interplay between COVID-19 and CV disease is required for optimum management of these patients.
       </abstracttext>
       <abstracttext label="METHODS" nlmcategory="METHODS">
        A literature search was done using PubMed and Google search engines to prepare a narrative review on this topic.
       </abstracttext>
       <abstracttext label="RESULTS" nlmcategory="RESULTS">
        Respiratory illness is the dominant clinical manifestation of COVID-19; CV involvement occurs much less commonly. Acute cardiac injury, defined as significant elevation of cardiac troponins, is the most commonly reported cardiac abnormality in COVID-19. It occurs in approximately 8-12% of all patients. Direct myocardial injury due to viral involvement of cardiomyocytes and the effect of systemic inflammation appear to be the most common mechanisms responsible for cardiac injury. The information about other CV manifestations in COVID-19 is very limited at present. Nonetheless, it has been consistently shown that the presence of pre-existing CV disease and/or development of acute cardiac injury are associated with significantly worse outcome in these patients.
       </abstracttext>
       <abstracttext label="CONCLUSIONS" nlmcategory="CONCLUSIONS">
        Most of the current reports on COVID-19 have only briefly described CV manifestations in these patients. Given the enormous burden posed by this illness and the significant adverse prognostic impact of cardiac involvement, further research is required to understand the incidence, mechanisms, clinical presentation and outcomes of various CV manifestations in COVID-19 patients.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Bansal
        </lastname>
        <forename>
         Manish
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Clinical and Preventive Cardiology, Medanta- the Medicity, Sector 38, Gurgaon, Haryana, 122001, India. Electronic address: manishaiims@hotmail.com.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        25
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Netherlands
      </country>
      <medlineta>
       Diabetes Metab Syndr
      </medlineta>
      <nlmuniqueid>
       101462250
      </nlmuniqueid>
      <issnlinking>
       1871-4021
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       Arrhythmia
      </keyword>
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       Cardiac troponins
      </keyword>
      <keyword majortopicyn="N">
       Cardiogenic shock
      </keyword>
      <keyword majortopicyn="N">
       Coronavirus disease 2019
      </keyword>
      <keyword majortopicyn="N">
       Heart failure
      </keyword>
      <keyword majortopicyn="N">
       Myocardial infarction
      </keyword>
      <keyword majortopicyn="N">
       Myocarditis
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV-2
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32247212
      </articleid>
      <articleid idtype="pii">
       S1871-4021(20)30053-9
      </articleid>
      <articleid idtype="doi">
       10.1016/j.dsx.2020.03.013
      </articleid>
      <articleid idtype="pmc">
       PMC7102662
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="PubMed-not-MEDLINE">
     <pmid version="1">
      27885969
     </pmid>
     <daterevised>
      <year>
       2019
      </year>
      <month>
       11
      </month>
      <day>
       20
      </day>
     </daterevised>
     <article pubmodel="Electronic">
      <journal>
       <issn issntype="Electronic">
        1466-609X
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         20
        </volume>
        <issue>
         Suppl 2
        </issue>
        <pubdate>
         <year>
          2016
         </year>
         <month>
          04
         </month>
         <day>
          20
         </day>
        </pubdate>
       </journalissue>
       <title>
        Critical care (London, England)
       </title>
       <isoabbreviation>
        Crit Care
       </isoabbreviation>
      </journal>
      <articletitle>
       36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
      </articletitle>
      <pagination>
       <medlinepgn>
        94
       </medlinepgn>
      </pagination>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2016
       </year>
       <month>
        04
       </month>
       <day>
        20
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       Crit Care
      </medlineta>
      <nlmuniqueid>
       9801902
      </nlmuniqueid>
      <issnlinking>
       1364-8535
      </issnlinking>
     </medlinejournalinfo>
     <commentscorrectionslist>
      <commentscorrections reftype="ErratumIn">
       <refsource>
        Crit Care. 2016 Oct 24;20:347
       </refsource>
       <pmid version="1">
        31268434
       </pmid>
      </commentscorrections>
     </commentscorrectionslist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2016
       </year>
       <month>
        11
       </month>
       <day>
        26
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2016
       </year>
       <month>
        11
       </month>
       <day>
        26
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2016
       </year>
       <month>
        11
       </month>
       <day>
        26
       </day>
       <hour>
        6
       </hour>
       <minute>
        1
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      epublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       27885969
      </articleid>
      <articleid idtype="doi">
       10.1186/s13054-016-1208-6
      </articleid>
      <articleid idtype="pii">
       10.1186/s13054-016-1208-6
      </articleid>
      <articleid idtype="pmc">
       PMC5493079
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32297133
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       16
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1573-742X
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          15
         </day>
        </pubdate>
       </journalissue>
       <title>
        Journal of thrombosis and thrombolysis
       </title>
       <isoabbreviation>
        J. Thromb. Thrombolysis
       </isoabbreviation>
      </journal>
      <articletitle>
       Toward understanding the 2019 Coronavirus and its impact on the heart.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.1007/s11239-020-02107-6
      </elocationid>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Becker
        </lastname>
        <forename>
         Richard C
        </forename>
        <initials>
         RC
        </initials>
        <affiliationinfo>
         <affiliation>
          , Cincinnati, USA. beckerrc@ucmail.uc.edu.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016421">
        Editorial
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        15
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Netherlands
      </country>
      <medlineta>
       J Thromb Thrombolysis
      </medlineta>
      <nlmuniqueid>
       9502018
      </nlmuniqueid>
      <issnlinking>
       0929-5305
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32297133
      </articleid>
      <articleid idtype="doi">
       10.1007/s11239-020-02107-6
      </articleid>
      <articleid idtype="pii">
       10.1007/s11239-020-02107-6
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation indexingmethod="Curated" owner="NLM" status="MEDLINE">
     <pmid version="1">
      32267110
     </pmid>
     <datecompleted>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       09
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       09
      </day>
     </daterevised>
     <article pubmodel="Print">
      <journal>
       <issn issntype="Print">
        0370-629X
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         75
        </volume>
        <issue>
         4
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
        </pubdate>
       </journalissue>
       <title>
        Revue medicale de Liege
       </title>
       <isoabbreviation>
        Rev Med Liege
       </isoabbreviation>
      </journal>
      <articletitle>
       [COVID-19 andcardiovascular diseases].
      </articletitle>
      <pagination>
       <medlinepgn>
        226-232
       </medlinepgn>
      </pagination>
      <abstract>
       <abstracttext>
        COVID-2019 disease mainly affects the respiratory tract and can progress in severe cases to pneumonia, acute respiratory distress syndrome and multi-organ failure. Patients with prior cardiovascular disease are at higher risk of developing an infection and progressing to a severe form of the disease. Also, due to the growing number of infected cases, it is clear that, in addition to the typical respiratory symptoms caused by the infection, some patients suffer from cardiovascular damage. This condition can, in fact, cause significant myocardial damage, which worsens the disease and affects the prognosis. Based on the results of currently published research, it seems important to discuss the manifestations and characteristics of myocardial damage induced by COVID-19 and its impact on patient prognosis.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Haeck
        </lastname>
        <forename>
         G
        </forename>
        <initials>
         G
        </initials>
        <affiliationinfo>
         <affiliation>
          Service de Cardiologie, CHU Liège, Belgique.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ancion
        </lastname>
        <forename>
         A
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Service de Cardiologie, CHU Liège, Belgique.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Marechal
        </lastname>
        <forename>
         P
        </forename>
        <initials>
         P
        </initials>
        <affiliationinfo>
         <affiliation>
          Service de Cardiologie, CHU Liège, Belgique.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Oury
        </lastname>
        <forename>
         C
        </forename>
        <initials>
         C
        </initials>
        <affiliationinfo>
         <affiliation>
          GIGA Cardiovascular Sciences, ULiège, Belgique.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lancellotti
        </lastname>
        <forename>
         P
        </forename>
        <initials>
         P
        </initials>
        <affiliationinfo>
         <affiliation>
          Service de Cardiologie, CHU Liège, GIGA Cardiovascular Sciences, Liège, Belgique.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       fre
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <vernaculartitle>
       COVID-19 et maladies cardiovasculaires.
      </vernaculartitle>
     </article>
     <medlinejournalinfo>
      <country>
       Belgium
      </country>
      <medlineta>
       Rev Med Liege
      </medlineta>
      <nlmuniqueid>
       0404317
      </nlmuniqueid>
      <issnlinking>
       0370-629X
      </issnlinking>
     </medlinejournalinfo>
     <supplmeshlist>
      <supplmeshname type="Disease" ui="C000657245">
       COVID-19
      </supplmeshname>
      <supplmeshname type="Organism" ui="C000656484">
       severe acute respiratory syndrome coronavirus 2
      </supplmeshname>
     </supplmeshlist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D000073640">
        Betacoronavirus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000472">
        pathogenicity
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D002318">
        Cardiovascular Diseases
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015897">
        Comorbidity
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D009206">
        Myocardium
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000473">
        pathology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D058873">
        Pandemics
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D011024">
        Pneumonia, Viral
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011379">
        Prognosis
       </descriptorname>
      </meshheading>
     </meshheadinglist>
     <otherabstract language="fre" type="Publisher">
      <abstracttext>
       Le COVID-19 affecte principalement les voies respiratoires et peut évoluer, dans les cas graves, vers une pneumonie, un syndrome de détresse respiratoire aiguë et une défaillance multi-systémique. Les patients souffrant d’une atteinte cardiovasculaire préalable sont plus à risque de développer une infection et d’évoluer vers une forme grave de la maladie. Aussi, de par le nombre croissant de cas infectés, force est de constater, qu’en plus des symptômes respiratoires typiques causés par l’infection, certains patients souffrent d’atteintes cardiovasculaires. Cette affection peut, en effet, entraîner des dommages myocardiques importants, qui aggravent la maladie et affectent le pronostic. Sur base des résultats des recherches actuellement publiées, il nous semble important de discuter des manifestations et des caractéristiques des atteintes myocardiques induites par le COVID-19 et de son impact sur le pronostic.
      </abstracttext>
     </otherabstract>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       Cardiovascular disease
      </keyword>
      <keyword majortopicyn="N">
       Myocardial injury
      </keyword>
      <keyword majortopicyn="N">
       2019
      </keyword>
      <keyword majortopicyn="N">
       COVID
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        9
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        9
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        10
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32267110
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32171190
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       14
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Print">
        0253-3758
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         48
        </volume>
        <issue>
         0
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
         <day>
          15
         </day>
        </pubdate>
       </journalissue>
       <title>
        Zhonghua xin xue guan bing za zhi
       </title>
       <isoabbreviation>
        Zhonghua Xin Xue Guan Bing Za Zhi
       </isoabbreviation>
      </journal>
      <articletitle>
       [Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].
      </articletitle>
      <pagination>
       <medlinepgn>
        E011
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.3760/cma.j.cn112148-20200228-00137
      </elocationid>
      <abstract>
       <abstracttext>
        <b>
         Objective:
        </b>
        To analyze the clinical characteristics of the severe or critically ill patients with novel coronavirus pneumonia (COVID-19), and evaluate the impact of complicated myocardial injury on the prognosis of these patients.
        <b>
         Methods:
        </b>
        A retrospective study was conducted in 54 patients who admitted to Tongji hospital from February 3, 2020 to February 24, 2020 and met the criteria of severe or critical conditions of COVID-19. The clinical characteristics and hospital mortality rate were analyzed and compared between the patients with or without myocardial injury, which was defined with 3 times higher serum cardiac troponin value.
        <b>
         Results:
        </b>
        The median age of the 54 patients was 68 (59.8, 74.3) years. Among all the patients, 24 (44.4%) patients were complicated with hypertension, 13 (24.1%) with diabetes, 8 (14.8%) with coronary heart disease, and 3 (5.6%) with previous cerebral infarction. During hospitalization, 24 (44.4%) of the patients were complicated with myocardial injury and 26 (48.1%) patients died in hospital. In-hospital mortality was significantly higher in patients with myocardial injury than in patients without myocardial injury (14 (60.9%) vs. 8 (25.8%),
        <i>
         P
        </i>
        =0.013). Moreover, the levels of C-reactive protein (153.6 (80.3, 240.7) ng/L vs. 49.8 (15.9, 101.9) ng/L) and N-terminal pro-B-type natriuretic peptide (852.0 (400.0, 2 315.3) ng/L vs. 197.0 (115.3, 631.0) ng/L) were significantly higher than patients without myocardial injury (all
        <i>
         P
        </i>
        &lt;0.01).
        <b>
         Conclusions:
        </b>
        Prevalence of myocardial injury is high among severe or critically ill COVID-19 patients. Severe or critically ill COVID-19 patients with myocardial injury face a significantly higher risk of in-hospital mortality. The study suggests that it is important to monitor and manage the myocardial injury during hospitalization for severe or critically ill COVID-19 patients.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         He
        </lastname>
        <forename>
         X W
        </forename>
        <initials>
         XW
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lai
        </lastname>
        <forename>
         J S
        </forename>
        <initials>
         JS
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cheng
        </lastname>
        <forename>
         J
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         M W
        </forename>
        <initials>
         MW
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Liu
        </lastname>
        <forename>
         Y J
        </forename>
        <initials>
         YJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Xiao
        </lastname>
        <forename>
         Z C
        </forename>
        <initials>
         ZC
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Xu
        </lastname>
        <forename>
         C
        </forename>
        <initials>
         C
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Li
        </lastname>
        <forename>
         S S
        </forename>
        <initials>
         SS
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Emergency, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Zeng
        </lastname>
        <forename>
         H S
        </forename>
        <initials>
         HS
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       chi
      </language>
      <publicationtypelist>
       <publicationtype ui="D004740">
        English Abstract
       </publicationtype>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        15
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       China
      </country>
      <medlineta>
       Zhonghua Xin Xue Guan Bing Za Zhi
      </medlineta>
      <nlmuniqueid>
       7910682
      </nlmuniqueid>
      <issnlinking>
       0253-3758
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <otherabstract language="chi" type="Publisher">
      <abstracttext>
       <b>
        目的：
       </b>
       分析重型/危重型新型冠状病毒肺炎（COVID-19）的临床特征，评估合并心肌损伤对患者预后的影响。
       <b>
        方法：
       </b>
       回顾性分析2020年2月3日至2020年2月24日于华中科技大学同济医学院附属同济医院中法新城院区收治的54例重型/危重型COVID-19确诊病例，年龄68.0（59.8，74.3）岁，男34例（63.0%），分析其临床特征。并根据是否合并心肌损伤（高敏心肌肌钙蛋白&gt;正常上限3倍以上，并排除急性心肌梗死、心功能不全失代偿、慢性肾功能衰竭）将患者分为合并心肌损伤组和未合并心肌损伤组，比较两组患者临床特征的差异。
       <b>
        结果：
       </b>
       所有患者中合并高血压24例（44.4%），糖尿病13例（24.1%），冠心病8例（14.8%），既往脑梗死3例（5.6%）。住院期间合并心肌损伤24例（44.4%），院内死亡26例（48.1%）。按有无心肌损伤将患者分为合并心肌损伤组（24例）和未合并心肌损伤组（30例）。两组在年龄、性别、合并症等方面差异均无明显统计学意义（
       <i>
        P
       </i>
       均&lt;0.05）。但心肌损伤组患者，院内死亡率明显高于未合并心肌损伤组[75.0%（18/24）比26.7%（8/30），
       <i>
        P
       </i>
       =0.001]。同时心肌损伤组的C反应蛋白[153.6（80.3, 240.7）ng/L比49.8（15.9, 101.9）ng/L]和氨基末端B型利钠肽原[852.0（400.0, 2 315.3）ng/L比197.0（115.3, 631.0）ng/L]水平也明显高于未合并心肌损伤组（
       <i>
        P
       </i>
       均&lt;0.01）。
       <b>
        结论：
       </b>
       重型/危重型COVID-19多为老年患者，合并症多，发生心肌损伤的比例高。合并心肌损伤的患者具有更高的院内死亡率。因此，应加强住院期间心肌损伤标记物和心功能的监测，重视合并心肌损伤的治疗。.
      </abstracttext>
     </otherabstract>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       Myocardial injury
      </keyword>
      <keyword majortopicyn="N">
       Troponin
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        15
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32171190
      </articleid>
      <articleid idtype="doi">
       10.3760/cma.j.cn112148-20200228-00137
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32305557
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       19
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1873-1740
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          16
         </day>
        </pubdate>
       </journalissue>
       <title>
        Progress in cardiovascular diseases
       </title>
       <isoabbreviation>
        Prog Cardiovasc Dis
       </isoabbreviation>
      </journal>
      <articletitle>
       The impact of 2019 novel coronavirus on heart injury: A systemic review and Meta-analysis.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       S0033-0620(20)30080-3
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.pcad.2020.04.008
      </elocationid>
      <abstract>
       <abstracttext label="BACKGROUND" nlmcategory="BACKGROUND">
        Evidence about COVID-19 on cardiac injury is inconsistent.
       </abstracttext>
       <abstracttext label="OBJECTIVES" nlmcategory="OBJECTIVE">
        We aimed to summarize available data on severity differences in acute cardiac injury and acute cardiac injury with mortality during the COVID-19 outbreak.
       </abstracttext>
       <abstracttext label="METHODS" nlmcategory="METHODS">
        We performed a systematic literature search across Pubmed, Embase and pre-print from December 1, 2019 to March 27, 2020, to identify all observational studies that reported cardiac specific biomarkers (troponin, creatine kinase-MB fraction, myoglobin, or NT-proBNP) during COVID-19 infection. We extracted data on patient demographics, infection severity, comorbidity history, and biomarkers during COVID-19 infection. Where possible, data were pooled for meta-analysis with standard (SMD) or weighted (WMD) mean difference and corresponding 95% confidence intervals (CI).
       </abstracttext>
       <abstracttext label="RESULTS" nlmcategory="RESULTS">
        We included 4189 confirmed COVID-19 infected patients from 28 studies. More severe COVID-19 infection is associated with higher mean troponin (SMD 0.53, 95% CI 0.30 to 0.75, p &lt; 0.001), with a similar trend for creatine kinase-MB, myoglobin, and NT-proBNP. Acute cardiac injury was more frequent in those with severe, compared to milder, disease (risk ratio 5.99, 3.04 to 11.80; p &lt; 0.001). Meta regression suggested that cardiac injury biomarker differences of severity are related to history of hypertension (p = 0.030). Also COVID19-related cardiac injury is associated with higher mortality (summary risk ratio 3.85, 2.13 to 6.96; p &lt; 0.001). hsTnI and NT-proBNP levels increased during the course of hospitalization only in non-survivors.
       </abstracttext>
       <abstracttext label="CONCLUSION" nlmcategory="CONCLUSIONS">
        The severity of COVID-19 is associated with acute cardiac injury, and acute cardiac injury is associated with death. Cardiac injury biomarkers mainly increase in non-survivors. This highlights the need to effectively monitor heart health to prevent myocarditis in patients infected with COVID-19.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2020. Published by Elsevier Inc.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Li
        </lastname>
        <forename>
         Jing-Wei
        </forename>
        <initials>
         JW
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, People's Liberation Army General Hospital, Beijing, China; The George Institute for Global Health, Faculty of Medicine, University of New South Wales, NSW, Australia; Department of Cardiology, Xinqiao Hospital, Army Military Medical University, Chongqing, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Han
        </lastname>
        <forename>
         Tian-Wen
        </forename>
        <initials>
         TW
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, People's Liberation Army General Hospital, Beijing, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Woodward
        </lastname>
        <forename>
         Mark
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          The George Institute for Global Health, Faculty of Medicine, University of New South Wales, NSW, Australia; The George Institute for Global Health, University of Oxford, Oxford, UK; Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Anderson
        </lastname>
        <forename>
         Craig S
        </forename>
        <initials>
         CS
        </initials>
        <affiliationinfo>
         <affiliation>
          The George Institute for Global Health, Faculty of Medicine, University of New South Wales, NSW, Australia; The George Institute China at Peking University Health Science Center, Beijing, PR China; Heart Health Research Center, Beijing, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Zhou
        </lastname>
        <forename>
         Hao
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, People's Liberation Army General Hospital, Beijing, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chen
        </lastname>
        <forename>
         Yun-Dai
        </forename>
        <initials>
         YD
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Cardiology, People's Liberation Army General Hospital, Beijing, China. Electronic address: cyundai@vip.163.com.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Neal
        </lastname>
        <forename>
         Bruce
        </forename>
        <initials>
         B
        </initials>
        <affiliationinfo>
         <affiliation>
          The George Institute for Global Health, Faculty of Medicine, University of New South Wales, NSW, Australia; Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D016454">
        Review
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        16
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Prog Cardiovasc Dis
      </medlineta>
      <nlmuniqueid>
       0376442
      </nlmuniqueid>
      <issnlinking>
       0033-0620
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      AIM
     </citationsubset>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       Cardiac injury
      </keyword>
      <keyword majortopicyn="N">
       Coronavirus
      </keyword>
      <keyword majortopicyn="N">
       Mortality
      </keyword>
     </keywordlist>
     <coistatement>
      Declaration of competing interest BN is supported by an Australian National Health and Medical Research Council Principal Research Fellowship; holds a research grant for this study from Janssen; and has held research grants for other large­scale cardiovascular outcome trials from Roche, Servier, and Merck Schering Plough; and his institution has received consultancy, honoraria, or travel support for contributions he has made to advisory boards or the continuing medical education programmes of Abbott, Janssen, Novartis, Pfizer, Roche, and Servier. MW is a consultant for Amgen, Inc., and Kirin. CA holds a NHMRC Senior Principal Research Fellowship and has received fees from Boehringer Ingelheim and Amgen for participating in advisory panels, from Takeda China and Boehringer Ingelheim for speaking at seminars, and a research grant from Takeda China paid to his institution. The other authors have no disclosures.
     </coistatement>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        12
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        12
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        20
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        20
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        20
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32305557
      </articleid>
      <articleid idtype="pii">
       S0033-0620(20)30080-3
      </articleid>
      <articleid idtype="doi">
       10.1016/j.pcad.2020.04.008
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      19453650
     </pmid>
     <datecompleted>
      <year>
       2010
      </year>
      <month>
       02
      </month>
      <day>
       22
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       18
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1365-2362
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         39
        </volume>
        <issue>
         7
        </issue>
        <pubdate>
         <year>
          2009
         </year>
         <month>
          Jul
         </month>
        </pubdate>
       </journalissue>
       <title>
        European journal of clinical investigation
       </title>
       <isoabbreviation>
        Eur. J. Clin. Invest.
       </isoabbreviation>
      </journal>
      <articletitle>
       SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.
      </articletitle>
      <pagination>
       <medlinepgn>
        618-25
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1111/j.1365-2362.2009.02153.x
      </elocationid>
      <abstract>
       <abstracttext label="BACKGROUND" nlmcategory="BACKGROUND">
        Angiotensin converting enzyme 2 (ACE2), a monocarboxylase that degrades angiotensin II to angiotensin 1-7, is also the functional receptor for severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) and is highly expressed in the lungs and heart. Patients with SARS also suffered from cardiac disease including arrhythmias, sudden cardiac death, and systolic and diastolic dysfunction.
       </abstracttext>
       <abstracttext label="MATERIALS AND METHODS" nlmcategory="METHODS">
        We studied mice infected with the human strain of the SARS-CoV and encephalomyocarditis virus and examined ACE2 mRNA and protein expression. Autopsy heart samples from patients who succumbed to the SARS crisis in Toronto (Canada) were used to investigate the impact of SARS on myocardial structure, inflammation and ACE2 protein expression.
       </abstracttext>
       <abstracttext label="RESULTS" nlmcategory="RESULTS">
        Pulmonary infection with the human SARS-CoV in mice led to an ACE2-dependent myocardial infection with a marked decrease in ACE2 expression confirming a critical role of ACE2 in mediating SARS-CoV infection in the heart. The SARS-CoV viral RNA was detected in 35% (7/20) of autopsied human heart samples obtained from patients who succumbed to the SARS crisis during the Toronto SARS outbreak. Macrophage-specific staining showed a marked increase in macrophage infiltration with evidence of myocardial damage in patients who had SARS-CoV in their hearts. The presence of SARS-CoV in the heart was also associated with marked reductions in ACE2 protein expression.
       </abstracttext>
       <abstracttext label="CONCLUSIONS" nlmcategory="CONCLUSIONS">
        Our data show that SARS-CoV can mediate myocardial inflammation and damage associated with down-regulation of myocardial ACE2 system, which may be responsible for the myocardial dysfunction and adverse cardiac outcomes in patients with SARS.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Oudit
        </lastname>
        <forename>
         G Y
        </forename>
        <initials>
         GY
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. gavin.oudit@ualberta.ca
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Kassiri
        </lastname>
        <forename>
         Z
        </forename>
        <initials>
         Z
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Jiang
        </lastname>
        <forename>
         C
        </forename>
        <initials>
         C
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Liu
        </lastname>
        <forename>
         P P
        </forename>
        <initials>
         PP
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Poutanen
        </lastname>
        <forename>
         S M
        </forename>
        <initials>
         SM
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Penninger
        </lastname>
        <forename>
         J M
        </forename>
        <initials>
         JM
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Butany
        </lastname>
        <forename>
         J
        </forename>
        <initials>
         J
        </initials>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D013485">
        Research Support, Non-U.S. Gov't
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2009
       </year>
       <month>
        05
       </month>
       <day>
        06
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       Eur J Clin Invest
      </medlineta>
      <nlmuniqueid>
       0245331
      </nlmuniqueid>
      <issnlinking>
       0014-2972
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        EC 3.4.15.1
       </registrynumber>
       <nameofsubstance ui="D007703">
        Peptidyl-Dipeptidase A
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        EC 3.4.17.-
       </registrynumber>
       <nameofsubstance ui="C413524">
        angiotensin converting enzyme 2
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000818">
        Animals
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D001344">
        Autopsy
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D002318">
        Cardiovascular Diseases
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000517">
        prevention &amp; control
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000821">
        virology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015536">
        Down-Regulation
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D007150">
        Immunohistochemistry
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008297">
        Male
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D051379">
        Mice
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D009206">
        Myocardium
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000473">
        pathology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D007703">
        Peptidyl-Dipeptidase A
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000378">
        metabolism
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D045473">
        SARS Virus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000378">
        metabolism
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D014775">
        Virus Activation
       </descriptorname>
      </meshheading>
     </meshheadinglist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2009
       </year>
       <month>
        5
       </month>
       <day>
        21
       </day>
       <hour>
        9
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2009
       </year>
       <month>
        5
       </month>
       <day>
        21
       </day>
       <hour>
        9
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2010
       </year>
       <month>
        2
       </month>
       <day>
        23
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       19453650
      </articleid>
      <articleid idtype="pii">
       ECI2153
      </articleid>
      <articleid idtype="doi">
       10.1111/j.1365-2362.2009.02153.x
      </articleid>
      <articleid idtype="pmc">
       PMC7163766
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2003 Jun 4;289(21):2801-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12734147
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Circulation. 2006 Feb 14;113(6):876-90
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16476862
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Circ Res. 2005 Aug 19;97(4):380-90
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16037568
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2002 Jun 20;417(6891):822-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12075344
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virus Res. 2008 Apr;133(1):13-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17374415
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 Dec 18;349(25):2468-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14681520
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Circulation. 2003 Oct 14;108(15):1798-803
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14504188
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Med. 2005 Aug;11(8):875-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16007097
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 Dec 18;349(25):2431-41
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14681510
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Trends Pharmacol Sci. 2004 Jun;25(6):291-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15165741
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 2005 Jan 15;191(2):193-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15609228
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Virol. 2007 Aug;81(16):8692-706
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17537853
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Mod Pathol. 2005 Jan;18(1):1-10
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15272286
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Circulation. 2004 Jul 6;110(1):46-50
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15210601
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Postgrad Med J. 2006 Feb;82(964):140-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16461478
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Invest. 1992 Nov;90(5):2022-30
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         1331179
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2003 Nov 27;426(6965):450-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14647384
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 May 15;348(20):1995-2005
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12671061
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Cardiovasc Res. 2007 Jul 1;75(1):29-39
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17499227
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14194-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16963558
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virology. 2006 Sep 30;353(2):474-81
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16860835
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Circ Res. 2000 Sep 1;87(5):E1-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         10969042
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2005 Jul 7;436(7047):112-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16001071
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7809-14
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18490652
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2003 Jul 16;290(3):367-73
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12865378
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Pathol. 2006 Jun;168(6):1808-20
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16723697
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Trends Cardiovasc Med. 2003 Apr;13(3):93-101
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12691672
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Hypertension. 2006 Apr;47(4):718-26
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16505206
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Biol Chem. 2008 Feb 8;283(6):3272-80
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18055455
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virus Res. 2008 Sep;136(1-2):8-15
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18554741
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Jan;10(1):20-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15078592
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Pathol. 2007 Aug;171(2):438-51
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17600118
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Med. 2004 Dec;10(12 Suppl):S88-97
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15577937
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation indexingmethod="Curated" owner="NLM" status="MEDLINE">
     <pmid version="1">
      25344230
     </pmid>
     <datecompleted>
      <year>
       2015
      </year>
      <month>
       04
      </month>
      <day>
       28
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2018
      </year>
      <month>
       12
      </month>
      <day>
       02
      </day>
     </daterevised>
     <article pubmodel="Electronic">
      <journal>
       <issn issntype="Electronic">
        1471-2105
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         15
        </volume>
        <pubdate>
         <year>
          2014
         </year>
         <month>
          Oct
         </month>
         <day>
          24
         </day>
        </pubdate>
       </journalissue>
       <title>
        BMC bioinformatics
       </title>
       <isoabbreviation>
        BMC Bioinformatics
       </isoabbreviation>
      </journal>
      <articletitle>
       Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies.
      </articletitle>
      <pagination>
       <medlinepgn>
        333
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1186/1471-2105-15-333
      </elocationid>
      <abstract>
       <abstracttext label="BACKGROUND" nlmcategory="BACKGROUND">
        Infections are often associated to comorbidity that increases the risk of medical conditions which can lead to further morbidity and mortality. SARS is a threat which is similar to MERS virus, but the comorbidity is the key aspect to underline their different impacts. One UK doctor says "I'd rather have HIV than diabetes" as life expectancy among diabetes patients is lower than that of HIV. However, HIV has a comorbidity impact on the diabetes.
       </abstracttext>
       <abstracttext label="RESULTS" nlmcategory="RESULTS">
        We present a quantitative framework to compare and explore comorbidity between diseases. By using neighbourhood based benchmark and topological methods, we have built comorbidity relationships network based on the OMIM and our identified significant genes. Then based on the gene expression, PPI and signalling pathways data, we investigate the comorbidity association of these 2 infective pathologies with other 7 diseases (heart failure, kidney disorder, breast cancer, neurodegenerative disorders, bone diseases, Type 1 and Type 2 diabetes). Phenotypic association is measured by calculating both the Relative Risk as the quantified measures of comorbidity tendency of two disease pairs and the ϕ-correlation to measure the robustness of the comorbidity associations. The differential gene expression profiling strongly suggests that the response of SARS affected patients seems to be mainly an innate inflammatory response and statistically dysregulates a large number of genes, pathways and PPIs subnetworks in different pathologies such as chronic heart failure (21 genes), breast cancer (16 genes) and bone diseases (11 genes). HIV-1 induces comorbidities relationship with many other diseases, particularly strong correlation with the neurological, cancer, metabolic and immunological diseases. Similar comorbidities risk is observed from the clinical information. Moreover, SARS and HIV infections dysregulate 4 genes (ANXA3, GNS, HIST1H1C, RASA3) and 3 genes (HBA1, TFRC, GHITM) respectively that affect the ageing process. It is notable that HIV and SARS similarly dysregulated 11 genes and 3 pathways. Only 4 significantly dysregulated genes are common between SARS-CoV and MERS-CoV, including NFKBIA that is a key regulator of immune responsiveness implicated in susceptibility to infectious and inflammatory diseases.
       </abstracttext>
       <abstracttext label="CONCLUSIONS" nlmcategory="CONCLUSIONS">
        Our method presents a ripe opportunity to use data-driven approaches for advancing our current knowledge on disease mechanism and predicting disease comorbidities in a quantitative way.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Moni
        </lastname>
        <forename>
         Mohammad Ali
        </forename>
        <initials>
         MA
        </initials>
        <affiliationinfo>
         <affiliation>
          Computer Laboratory, University of Cambridge, William Gates Building, 15 JJ Thomson Avenue, Cambridge CB3 0FD, UK. Mohammad.Moni@cl.cam.ac.uk.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Liò
        </lastname>
        <forename>
         Pietro
        </forename>
        <initials>
         P
        </initials>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D013485">
        Research Support, Non-U.S. Gov't
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2014
       </year>
       <month>
        10
       </month>
       <day>
        24
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       BMC Bioinformatics
      </medlineta>
      <nlmuniqueid>
       100965194
      </nlmuniqueid>
      <issnlinking>
       1471-2105
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D002908">
        Chronic Disease
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015897">
        Comorbidity
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015658">
        HIV Infections
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000453">
        epidemiology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000276">
        immunology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000821">
        virology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015497">
        HIV-1
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000502">
        physiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D060066">
        Protein Interaction Maps
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012307">
        Risk Factors
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D045473">
        SARS Virus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000502">
        physiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D045169">
        Severe Acute Respiratory Syndrome
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000453">
        epidemiology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000276">
        immunology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000821">
        virology
       </qualifiername>
      </meshheading>
     </meshheadinglist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2013
       </year>
       <month>
        12
       </month>
       <day>
        30
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2014
       </year>
       <month>
        09
       </month>
       <day>
        19
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2014
       </year>
       <month>
        10
       </month>
       <day>
        26
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2014
       </year>
       <month>
        10
       </month>
       <day>
        26
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2015
       </year>
       <month>
        4
       </month>
       <day>
        29
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      epublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       25344230
      </articleid>
      <articleid idtype="pii">
       1471-2105-15-333
      </articleid>
      <articleid idtype="doi">
       10.1186/1471-2105-15-333
      </articleid>
      <articleid idtype="pmc">
       PMC4363349
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        PLoS One. 2010;5(1):e8729
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20090954
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Lancet Infect Dis. 2013 May;13(5):436-48
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23531392
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Kidney Int. 2005 Apr;67(4):1622-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15780120
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Blood. 2005 Oct 1;106(7):2366-74
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15860669
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16199517
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Immunol Rev. 2011 Mar;240(1):141-59
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21349092
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2007 May 22;104(21):8685-90
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17502601
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Mol Syst Biol. 2009;5:262
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19357641
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        N Engl J Med. 2009 Nov 12;361(20):1935-44
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19815859
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        MBio. 2013;4(3):e00165-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23631916
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Crit Rev Oncol Hematol. 2012 Feb;81(2):196-205
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21536452
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Euro Surveill. 2012;17(40):20290
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23078800
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Diabetes Care. 2012 Feb;35(2):299-304
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22266734
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Respirology. 2003 Nov;8 Suppl:S36-40
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15018132
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nucleic Acids Res. 2010 Jul;38(Web Server issue):W239-45
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20525784
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Sci Rep. 2012;2:757
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23091697
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Annu Rev Med. 2011;62:141-55
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21090961
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Virology. 2011 Jan 5;409(1):102-12
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21035159
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Bioinformatics. 2011 Feb 1;27(3):431-2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21149340
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Am J Med. 2008 Apr;121(4):258-64
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18374680
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Genome Biol. 2005;6(2):R16
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15693945
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nature. 2005 Oct 20;437(7062):1173-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16189514
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Genome Res. 2003 Nov;13(11):2498-504
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14597658
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nature. 2008 Jul 24;454(7203):428-35
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18650913
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        N Engl J Med. 2012 Nov 8;367(19):1814-20
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23075143
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Curr Pharm Des. 2006;12(9):1023-44
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16515484
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Mech Ageing Dev. 2014 Mar-Apr;136-137:138-47
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24462698
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Int J Cancer. 2008 Jul 1;123(1):187-94
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18435450
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Immun Ageing. 2014 Mar 19;11(1):4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24642138
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Clin Bioinforma. 2014 May 23;4:8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25045465
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Biotechnol. 2007 Mar;25(3):309-16
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17344885
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Med Virol. 2008 Sep;80(9):1507-14
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18649336
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Rev Cancer. 2013 May;13(5):357-65
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23612461
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Rev Cardiol. 2014 Jun;11(6):335-45
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24710495
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nucleic Acids Res. 2013 Jan;41(Database issue):D1027-33
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23193293
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Am Thorac Soc. 2008 May 1;5(4):549-55
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18453370
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nucleic Acids Res. 2005 Jan 1;33(Database issue):D514-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15608251
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nucleic Acids Res. 2009 Jan;37(Database issue):D767-72
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18988627
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        BMC Public Health. 2009;9:88
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19320986
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11694-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17609372
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Immunol Rev. 2012 Jan;245(1):209-26
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22168422
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Drug Discov Today. 2012 Dec;17(23-24):1289-98
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22889966
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Clin Endocrinol Metab. 2007 Sep;92(9):3705-11
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17595242
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Clin Pathol. 2007 Dec;60(12):1365-72
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18042692
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Bioinformatics. 2006 May 1;22(9):1096-102
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16481333
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Natl Cancer Inst. 2009 Aug 19;101(16):1120-30
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19648510
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Patholog Res Int. 2011;2011:359242
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21660263
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nucleic Acids Res. 2007 Jan;35(Database issue):D760-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17099226
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        BMC Immunol. 2005;6:2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15655079
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Diabetes Care. 2009 Sep;32(9):1620-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19564453
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS Comput Biol. 2009 Apr;5(4):e1000353
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19360091
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Lancet. 2007 Jul 7;370(9581):59-67
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17617273
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Chest. 2014 Jun;145(6):1244-54
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24458266
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS One. 2011;6(7):e22670
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21829475
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):9880-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18599447
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S21-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22209926
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Behav Brain Sci. 2010 Jun;33(2-3):137-50; discussion 150-93
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20584369
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS Pathog. 2013;9(7):e1003467
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23853589
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nucleic Acids Res. 2005 Jan 1;33(Database issue):D428-32
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15608231
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Infect Dis Clin North Am. 2010 Mar;24(1):175-202
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20171552
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Stroke. 2009 Oct;40(10):3206-10
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19679842
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Bioinformatics. 2009 Apr 1;25(7):875-81
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19189975
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4323-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18326631
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Hum Mutat. 2011 May;32(5):564-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21472891
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2007 Aug;81(16):8692-706
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17537853
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Physiol Genomics. 2009 Aug 7;38(3):233-40
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19336532
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS Comput Biol. 2010 Feb;6(2):e1000662
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20140234
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        AIDS. 2010 Jun 19;24(10):1415-23
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20495440
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nucleic Acids Res. 2009 Jan;37(Database issue):D793-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18842627
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Infect Dev Ctries. 2013 Jun;7(6):497-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23771295
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        BMC Public Health. 2008;8:221
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18582390
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Expert Rev Anticancer Ther. 2006 Nov;6(11):1553-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17134360
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Cell. 2005 Sep 23;122(6):957-68
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16169070
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Rambam Maimonides Med J. 2013 Apr 30;4(2):e0012
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23908862
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nature. 2007 Oct 4;449(7162):557-63
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17914389
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS One. 2012;7(3):e32678
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22403694
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Mol Syst Biol. 2009;5:252
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19308092
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS Genet. 2007 Jun;3(6):e98
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17571925
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        BMC Bioinformatics. 2012;13 Suppl 14:S12
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23095605
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Lancet Infect Dis. 2013 Sep;13(9):752-61
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23891402
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Hum Mutat. 2011 May;32(5):512-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21309042
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Rev Genet. 2009 Jan;10(1):43-55
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19092835
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Global Health. 2009 Sep 14;5:9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19751503
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        BMC Bioinformatics. 2006;7 Suppl 5:S19
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17254303
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        BMC Genomics. 2009;10:388
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19698090
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Lancet. 2010 May 1;375(9725):1525-35
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20435227
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20689501
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      28131646
     </pmid>
     <datecompleted>
      <year>
       2017
      </year>
      <month>
       02
      </month>
      <day>
       27
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       09
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1532-2939
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         95
        </volume>
        <issue>
         3
        </issue>
        <pubdate>
         <year>
          2017
         </year>
         <month>
          Mar
         </month>
        </pubdate>
       </journalissue>
       <title>
        The Journal of hospital infection
       </title>
       <isoabbreviation>
        J. Hosp. Infect.
       </isoabbreviation>
      </journal>
      <articletitle>
       Resource impact of managing suspected Middle East respiratory syndrome patients in a UK teaching hospital.
      </articletitle>
      <pagination>
       <medlinepgn>
        280-285
       </medlinepgn>
      </pagination>
      <elocationid eidtype="pii" validyn="Y">
       S0195-6701(16)30581-3
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.jhin.2016.12.010
      </elocationid>
      <abstract>
       <abstracttext>
        Clinical challenges exist in the management of hospitalized patients returning to the UK with potential Middle East respiratory syndrome coronavirus (MERS-CoV) infection, particularly with its clinical overlap with influenza, as demonstrated in this case-series and cost-analysis review of returning Hajj pilgrims. These patients were hospitalized with acute febrile respiratory illness, initially managed as potential MERS-CoV infections, but were eventually diagnosed with influenza. Additional costs were small, yet enhanced infection prevention measures created significant burdens on isolation rooms and staff time. Planning for predictable events such as Hajj is important for resource management. Here, in-house MERS-CoV diagnostic testing would have facilitated earlier diagnosis and discharge.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2016 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Veater
        </lastname>
        <forename>
         J
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Infectious Diseases Unit, University Hospitals Leicester NHS Trust, Leicester, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wong
        </lastname>
        <forename>
         N
        </forename>
        <initials>
         N
        </initials>
        <affiliationinfo>
         <affiliation>
          Infectious Diseases Unit, University Hospitals Leicester NHS Trust, Leicester, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Stephenson
        </lastname>
        <forename>
         I
        </forename>
        <initials>
         I
        </initials>
        <affiliationinfo>
         <affiliation>
          Infectious Diseases Unit, University Hospitals Leicester NHS Trust, Leicester, UK; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Kirk-Granger
        </lastname>
        <forename>
         H
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Clinical Microbiology, University Hospitals Leicester NHS Trust, Leicester, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Baxter
        </lastname>
        <forename>
         L F
        </forename>
        <initials>
         LF
        </initials>
        <affiliationinfo>
         <affiliation>
          Clinical Microbiology, University Hospitals Leicester NHS Trust, Leicester, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cannon
        </lastname>
        <forename>
         R
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Clinical Microbiology, University Hospitals Leicester NHS Trust, Leicester, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wilson
        </lastname>
        <forename>
         S
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          Public Health Birmingham, National Infection Service, Public Health England, Heart of England NHS Foundation Trust, Heartlands Hospital, Birmingham, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Atabani
        </lastname>
        <forename>
         S
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          Public Health Birmingham, National Infection Service, Public Health England, Heart of England NHS Foundation Trust, Heartlands Hospital, Birmingham, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sahota
        </lastname>
        <forename>
         A
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Infectious Diseases Unit, University Hospitals Leicester NHS Trust, Leicester, UK; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bell
        </lastname>
        <forename>
         D
        </forename>
        <initials>
         D
        </initials>
        <affiliationinfo>
         <affiliation>
          Infectious Diseases Unit, University Hospitals Leicester NHS Trust, Leicester, UK; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wiselka
        </lastname>
        <forename>
         M
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Infectious Diseases Unit, University Hospitals Leicester NHS Trust, Leicester, UK; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Tang
        </lastname>
        <forename>
         J W
        </forename>
        <initials>
         JW
        </initials>
        <affiliationinfo>
         <affiliation>
          Clinical Microbiology, University Hospitals Leicester NHS Trust, Leicester, UK; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK. Electronic address: julian.tang@uhl-tr.nhs.uk.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D002363">
        Case Reports
       </publicationtype>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2016
       </year>
       <month>
        12
       </month>
       <day>
        18
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       J Hosp Infect
      </medlineta>
      <nlmuniqueid>
       8007166
      </nlmuniqueid>
      <issnlinking>
       0195-6701
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000328">
        Adult
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D019090">
        Case Management
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000191">
        economics
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000592">
        standards
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000175">
        diagnosis
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000628">
        therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D005260">
        Female
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D006295">
        Health Resources
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D017721">
        Hospital Costs
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006784">
        Hospitals, Teaching
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008297">
        Male
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008875">
        Middle Aged
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D014195">
        Travel
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006113">
        United Kingdom
       </descriptorname>
      </meshheading>
     </meshheadinglist>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="Y">
       Influenza
      </keyword>
      <keyword majortopicyn="Y">
       Isolation
      </keyword>
      <keyword majortopicyn="Y">
       Middle East respiratory syndrome
      </keyword>
      <keyword majortopicyn="Y">
       Personal protective equipment
      </keyword>
      <keyword majortopicyn="Y">
       Polymerase chain reaction
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2016
       </year>
       <month>
        08
       </month>
       <day>
        05
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2016
       </year>
       <month>
        12
       </month>
       <day>
        08
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2017
       </year>
       <month>
        1
       </month>
       <day>
        31
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2017
       </year>
       <month>
        2
       </month>
       <day>
        28
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2017
       </year>
       <month>
        1
       </month>
       <day>
        30
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       28131646
      </articleid>
      <articleid idtype="pii">
       S0195-6701(16)30581-3
      </articleid>
      <articleid idtype="doi">
       10.1016/j.jhin.2016.12.010
      </articleid>
      <articleid idtype="pmc">
       PMC7132460
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2014 Sep;20(9):1562-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25148267
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Int J Infect Dis. 2016 Jun;47:10-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27117200
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Euro Surveill. 2012 Sep 27;17(39):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23041020
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Virol. 2005 Aug;33(4):341-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15927526
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2015 Sep;21(9):1654-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26291541
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Med Virol. 2003 Jun;70(2):228-39
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12696109
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):480-3
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23760190
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      16607445
     </pmid>
     <datecompleted>
      <year>
       2006
      </year>
      <month>
       06
      </month>
      <day>
       23
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2016
      </year>
      <month>
       10
      </month>
      <day>
       13
      </day>
     </daterevised>
     <article pubmodel="Print">
      <journal>
       <issn issntype="Print">
        0929-6646
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         104
        </volume>
        <issue>
         12
        </issue>
        <pubdate>
         <year>
          2005
         </year>
         <month>
          Dec
         </month>
        </pubdate>
       </journalissue>
       <title>
        Journal of the Formosan Medical Association = Taiwan yi zhi
       </title>
       <isoabbreviation>
        J. Formos. Med. Assoc.
       </isoabbreviation>
      </journal>
      <articletitle>
       Acute renal failure in patients with severe acute respiratory syndrome.
      </articletitle>
      <pagination>
       <medlinepgn>
        891-6
       </medlinepgn>
      </pagination>
      <abstract>
       <abstracttext label="BACKGROUND AND PURPOSE" nlmcategory="OBJECTIVE">
        Severe acute respiratory syndrome (SARS) is caused by a new coronavirus, and results in respiratory failure. Acute renal failure (ARF) may also occur and/or complicate the disease course, however, its incidence, causes and impact in SARS patients are not known.
       </abstracttext>
       <abstracttext label="METHODS" nlmcategory="METHODS">
        ARF patients were identified from a total of 78 (33 men and 45 women) probable SARS cases admitted to a single hospital. The clinical features of patients with ARF were characterized, and the etiologies analyzed.
       </abstracttext>
       <abstracttext label="RESULTS" nlmcategory="RESULTS">
        Patients were assigned to ARF (n = 13; 17%) and non-ARF groups (n = 65). Patients with ARF were older than their non-ARF counterparts. ARF developed 7.2 +/- 4.3 days after admission. The incidence of ARF was higher in males (77% vs 35%; p &lt; 0.05). Comorbidities of diabetes and heart failure were more common in patients who developed ARF (38% vs 6%, p &lt; 0.01 and 38% vs 2%, p &lt; 0.001, respectively) and the incidence of respiratory failure (85% vs 26%, p &lt; 0.001) and mortality (77% vs 8%, p &lt; 0.001) were also higher. Multiple organ system failure usually accompanied ARF. Hypotension (77%) caused by nosocomial infections, gastrointestinal bleeding, or SARS per se, and rhabdomyolysis (43%) was associated with ARF in addition to pre-renal factors. Five patients in the ARF group and 1 female patient with end-stage renal failure underwent renal replacement therapy during hospitalization; however, both eventually died. Of the 16 medical staff performing renal replacement therapy, none was subsequently infected with SARS coronavirus.
       </abstracttext>
       <abstracttext label="CONCLUSIONS" nlmcategory="CONCLUSIONS">
        Development of ARF during the disease course in SARS patients is associated with catastrophic outcome. The cause of ARF in SARS patients is often associated with pre-renal factors, hypotension, rhabdomyolysis, and previous comorbidities including diabetes and old age. Universal precautions to prevent viral transmission are mandatory for medical staff performing renal replacement therapy.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Huang
        </lastname>
        <forename>
         Jenq-Wen
        </forename>
        <initials>
         JW
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chen
        </lastname>
        <forename>
         Kuan-Yu
        </forename>
        <initials>
         KY
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Tsai
        </lastname>
        <forename>
         Hung-Bin
        </forename>
        <initials>
         HB
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Wu
        </lastname>
        <forename>
         Vin-Cent
        </forename>
        <initials>
         VC
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Yang
        </lastname>
        <forename>
         Ya-Fei
        </forename>
        <initials>
         YF
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Wu
        </lastname>
        <forename>
         Ming-Shiou
        </forename>
        <initials>
         MS
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Chu
        </lastname>
        <forename>
         Tzong-Shinn
        </forename>
        <initials>
         TS
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Wu
        </lastname>
        <forename>
         Kwan-Dun
        </forename>
        <initials>
         KD
        </initials>
       </author>
       <author validyn="Y">
        <collectivename>
         SARS Research Group
        </collectivename>
       </author>
       <author validyn="Y">
        <collectivename>
         National Taiwan University College of Medicine
        </collectivename>
       </author>
       <author validyn="Y">
        <collectivename>
         National Taiwan University Hospital
        </collectivename>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D013485">
        Research Support, Non-U.S. Gov't
       </publicationtype>
      </publicationtypelist>
     </article>
     <medlinejournalinfo>
      <country>
       Singapore
      </country>
      <medlineta>
       J Formos Med Assoc
      </medlineta>
      <nlmuniqueid>
       9214933
      </nlmuniqueid>
      <issnlinking>
       0929-6646
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D058186">
        Acute Kidney Injury
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000209">
        etiology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000628">
        therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000368">
        Aged
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D016009">
        Chi-Square Distribution
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D005260">
        Female
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015994">
        Incidence
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008297">
        Male
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008875">
        Middle Aged
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D009102">
        Multiple Organ Failure
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D017582">
        Renal Replacement Therapy
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012307">
        Risk Factors
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D045169">
        Severe Acute Respiratory Syndrome
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D016019">
        Survival Analysis
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" type="Geographic" ui="D013624">
        Taiwan
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
      </meshheading>
     </meshheadinglist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2006
       </year>
       <month>
        4
       </month>
       <day>
        12
       </day>
       <hour>
        9
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2006
       </year>
       <month>
        6
       </month>
       <day>
        24
       </day>
       <hour>
        9
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2006
       </year>
       <month>
        4
       </month>
       <day>
        12
       </day>
       <hour>
        9
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       16607445
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32297987
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       16
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1096-9071
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          16
         </day>
        </pubdate>
       </journalissue>
       <title>
        Journal of medical virology
       </title>
       <isoabbreviation>
        J. Med. Virol.
       </isoabbreviation>
      </journal>
      <articletitle>
       Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.1002/jmv.25897
      </elocationid>
      <abstract>
       <abstracttext>
        The spread of the novel-Coronavirus infection worldwide represents a challenge for physicians. Particularly, no approved therapy has demonstrated to have an impact in treating patients who develop severe respiratory insufficiency so far. The use of humanized anti-human inteleukine-6 receptor antibody tocilizumab seems a promising strategy for these patients. This article is protected by copyright. All rights reserved.
       </abstracttext>
       <copyrightinformation>
        This article is protected by copyright. All rights reserved.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Di Giambenedetto
        </lastname>
        <forename>
         Simona
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, UOC Malattie Infettive.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Dipartimento di Sicurezza e Bioetica Sezione Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, Italia.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ciccullo
        </lastname>
        <forename>
         Arturo
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, UOC Malattie Infettive.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Borghetti
        </lastname>
        <forename>
         Alberto
        </forename>
        <initials>
         A
        </initials>
        <identifier source="ORCID">
         http://orcid.org/0000-0002-7910-021X
        </identifier>
        <affiliationinfo>
         <affiliation>
          Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, UOC Malattie Infettive.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gambassi
        </lastname>
        <forename>
         Giovanni
        </forename>
        <initials>
         G
        </initials>
        <affiliationinfo>
         <affiliation>
          Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma; Institute of Internal Medicine, "A. Gemelli Hospital", Catholic University of the Sacred Heart, Rome, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Landi
        </lastname>
        <forename>
         Francesco
        </forename>
        <initials>
         F
        </initials>
        <affiliationinfo>
         <affiliation>
          Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Rome, Italy.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Institute of Internal Medicine and Geriatrics, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Visconti
        </lastname>
        <forename>
         Elena
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, UOC Malattie Infettive.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Zileri Dal Verme
        </lastname>
        <forename>
         Lorenzo
        </forename>
        <initials>
         L
        </initials>
        <affiliationinfo>
         <affiliation>
          Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bernabei
        </lastname>
        <forename>
         Roberto
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, 00168, Rome, Italy.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Institute of Internal Medicine and Geriatrics, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Tamburrini
        </lastname>
        <forename>
         Enrica
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, UOC Malattie Infettive.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Dipartimento di Sicurezza e Bioetica Sezione Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, Italia.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cauda
        </lastname>
        <forename>
         Roberto
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, UOC Malattie Infettive.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Dipartimento di Sicurezza e Bioetica Sezione Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, Italia.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gasbarrini
        </lastname>
        <forename>
         Antonio
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italia.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <collectivename>
         GEMELLI AGAINST COVID-19 group (Members are listed in the Acknowledgments section)
        </collectivename>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016422">
        Letter
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        16
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       J Med Virol
      </medlineta>
      <nlmuniqueid>
       7705876
      </nlmuniqueid>
      <issnlinking>
       0146-6615
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV-2
      </keyword>
      <keyword majortopicyn="N">
       interstitial pneumonia
      </keyword>
      <keyword majortopicyn="N">
       tocilizumab
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32297987
      </articleid>
      <articleid idtype="doi">
       10.1002/jmv.25897
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="In-Data-Review">
     <pmid version="1">
      32235517
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       02
      </day>
     </daterevised>
     <article pubmodel="Electronic">
      <journal>
       <issn issntype="Electronic">
        1660-4601
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         17
        </volume>
        <issue>
         7
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
         <day>
          30
         </day>
        </pubdate>
       </journalissue>
       <title>
        International journal of environmental research and public health
       </title>
       <isoabbreviation>
        Int J Environ Res Public Health
       </isoabbreviation>
      </journal>
      <articletitle>
       Healthcare Digitalization and Pay-For-Performance Incentives in Smart Hospital Project Financing.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       E2318
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.3390/ijerph17072318
      </elocationid>
      <abstract>
       <abstracttext>
        This study aims to explore the impact of healthcare digitalization on smart hospital project financing (PF) fostered by pay-for-performance (P4P) incentives. Digital platforms are a technology-enabled business model that facilitates exchanges between interacting agents. They represent a bridging link among disconnected nodes, improving the scalable value of networks. Application to healthcare public-private partnerships (PPPs) is significant due to the consistency of digital platforms with health issues and the complexity of the stakeholder's interaction. In infrastructural PPPs, public and private players cooperate, usually following PF patterns. This relationship is complemented by digitized supply chains and is increasingly patient-centric. This paper reviews the literature, analyzes some supply chain bottlenecks, addresses solutions concerning the networking effects of platforms to improve PPP interactions, and investigates the cost-benefit analysis of digital health with an empirical case. Whereas diagnostic or infrastructural technology is an expensive investment with long-term payback, leapfrogging digital applications reduce contingent costs. "Digital" savings can be shared by key stakeholders with P4P schemes, incentivizing value co-creation patterns. Efficient sharing may apply network theory to a comprehensive PPP ecosystem where stakeholding nodes are digitally connected. This innovative approach improves stakeholder relationships, which are re-engineered around digital platforms that enhance patient-centered satisfaction and sustainability. Digital technologies are useful even for infectious disease surveillance, like that of the coronavirus pandemic, for supporting massive healthcare intervention, decongesting hospitals, and providing timely big data.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Moro Visconti
        </lastname>
        <forename>
         Roberto
        </forename>
        <initials>
         R
        </initials>
        <identifier source="ORCID">
         0000-0002-3458-5161
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Business Management, Catholic University of Sacred Heart, Via Ludovico Necchi, 7, 20123 Milan, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Morea
        </lastname>
        <forename>
         Donato
        </forename>
        <initials>
         D
        </initials>
        <identifier source="ORCID">
         0000-0003-0995-6685
        </identifier>
        <affiliationinfo>
         <affiliation>
          Faculty of Economics, Universitas Mercatorum, Piazza Mattei, 10, 00186 Rome, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        30
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Switzerland
      </country>
      <medlineta>
       Int J Environ Res Public Health
      </medlineta>
      <nlmuniqueid>
       101238455
      </nlmuniqueid>
      <issnlinking>
       1660-4601
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       coronavirus
      </keyword>
      <keyword majortopicyn="N">
       digital innovation
      </keyword>
      <keyword majortopicyn="N">
       healthcare bottlenecks
      </keyword>
      <keyword majortopicyn="N">
       healthcare sustainable development
      </keyword>
      <keyword majortopicyn="N">
       internet of medical things
      </keyword>
      <keyword majortopicyn="N">
       mHealth
      </keyword>
      <keyword majortopicyn="N">
       patient-centered care
      </keyword>
      <keyword majortopicyn="N">
       public–private partnerships
      </keyword>
      <keyword majortopicyn="N">
       results-based-financing
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        16
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="revised">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        23
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        25
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        3
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        3
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        3
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      epublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32235517
      </articleid>
      <articleid idtype="pii">
       ijerph17072318
      </articleid>
      <articleid idtype="doi">
       10.3390/ijerph17072318
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      2249724
     </pmid>
     <datecompleted>
      <year>
       1991
      </year>
      <month>
       01
      </month>
      <day>
       17
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2019
      </year>
      <month>
       05
      </month>
      <day>
       16
      </day>
     </daterevised>
     <article pubmodel="Print">
      <journal>
       <issn issntype="Print">
        0950-2688
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         105
        </volume>
        <issue>
         3
        </issue>
        <pubdate>
         <year>
          1990
         </year>
         <month>
          Dec
         </month>
        </pubdate>
       </journalissue>
       <title>
        Epidemiology and infection
       </title>
       <isoabbreviation>
        Epidemiol. Infect.
       </isoabbreviation>
      </journal>
      <articletitle>
       Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly.
      </articletitle>
      <pagination>
       <medlinepgn>
        609-18
       </medlinepgn>
      </pagination>
      <abstract>
       <abstracttext>
        Occupants of 482 long-stay and 33 short-stay beds in 11 Leicester City Council homes for the elderly were studied during a 30-week period from September 1988 to March 1989 to determine the incidence, aetiology, morbidity, and mortality of acute upper respiratory tract viral infections and the use of influenza vaccine. Influenza immunization rates by home ranged from 15.4 to 90% (mean 45%). There were no differences in the distribution of medical conditions by home. The highest immunization rates were seen in people with chest disease (77%), heart disease (60%), diabetes (56%), and those with three medical conditions (75%). There was an average of 0.7 upper respiratory episodes per bed per annum with a mortality of 3.4% (6/179). Half of all episodes were seen by a general medical practitioner and 81 of 90 (90%) referrals were prescribed antibiotics costing approximately 7.50 pounds per patient. Lower respiratory tract complications developed during 45 (25%) of 179 episodes including 3 of 12 coronavirus infections, 3 of 9 respiratory syncytial virus infections, 2 of 4 adenovirus infections, 1 of 11 rhinovirus infections, but none of 5 influenza infections. Respiratory infections were caused mostly by pathogens other than influenza virus during the influenza period documented nationally. This highlights the role of coronaviruses, respiratory syncytial virus, and unidentified agents in the elderly, and questions the assumptions made in American estimates on the impact of influenza and the value of influenza vaccines.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Nicholson
        </lastname>
        <forename>
         K G
        </forename>
        <initials>
         KG
        </initials>
        <affiliationinfo>
         <affiliation>
          Infectious Diseases Unit, Groby Road Hospital, Leicester.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Baker
        </lastname>
        <forename>
         D J
        </forename>
        <initials>
         DJ
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Farquhar
        </lastname>
        <forename>
         A
        </forename>
        <initials>
         A
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Hurd
        </lastname>
        <forename>
         D
        </forename>
        <initials>
         D
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Kent
        </lastname>
        <forename>
         J
        </forename>
        <initials>
         J
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Smith
        </lastname>
        <forename>
         S H
        </forename>
        <initials>
         SH
        </initials>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D013485">
        Research Support, Non-U.S. Gov't
       </publicationtype>
      </publicationtypelist>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       Epidemiol Infect
      </medlineta>
      <nlmuniqueid>
       8703737
      </nlmuniqueid>
      <issnlinking>
       0950-2688
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D007252">
        Influenza Vaccines
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000208">
        Acute Disease
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000368">
        Aged
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000369">
        Aged, 80 and over
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" type="Geographic" ui="D004739">
        England
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D005260">
        Female
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D006707">
        Homes for the Aged
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015994">
        Incidence
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D007252">
        Influenza Vaccines
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000008">
        administration &amp; dosage
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008297">
        Male
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D009017">
        Morbidity
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012141">
        Respiratory Tract Infections
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000453">
        epidemiology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000401">
        mortality
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012307">
        Risk Factors
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012737">
        Sex Factors
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D014777">
        Virus Diseases
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000453">
        epidemiology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000401">
        mortality
       </qualifiername>
      </meshheading>
     </meshheadinglist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        1990
       </year>
       <month>
        12
       </month>
       <day>
        1
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        1990
       </year>
       <month>
        12
       </month>
       <day>
        1
       </day>
       <hour>
        0
       </hour>
       <minute>
        1
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        1990
       </year>
       <month>
        12
       </month>
       <day>
        1
       </day>
       <hour>
        0
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       2249724
      </articleid>
      <articleid idtype="pmc">
       PMC2271825
      </articleid>
      <articleid idtype="doi">
       10.1017/s0950268800048251
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Epidemiol Rev. 1982;4:25-44
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6754408
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Lancet. 1984 Sep 15;2(8403):617-21
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6147649
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Infect. 1983 Nov;7(3):236-47
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6663083
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Vaccine. 1987 Dec;5(4):302-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         3433918
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Dev Biol Stand. 1977 Jun 1-3;39:317-21
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         604114
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        JAMA. 1961 Jun 3;176:776-82
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         13726091
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        U S Armed Forces Med J. 1958 Apr;9(4):469-78
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         13543964
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Am J Epidemiol. 1974 Jul;100(1):40-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         4858301
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Arch Intern Med. 1982 Jan;142(1):85-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         7053739
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Clin Microbiol. 1980 Oct;12(4):493-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6252244
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Infect Immun. 1982 Nov;38(2):419-23
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6292101
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Infect Dis. 1985 Jun;151(6):1170-1
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         3998514
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Infect. 1984 Nov;9(3):252-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6527041
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Infect. 1984 May;8(3):259-61
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6736667
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Br Med J. 1980 Nov 8;281(6250):1253-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         7427656
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Jpn J Tuberc Chest Dis. 1968 Dec;15(1):17-26
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         4906644
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        JAMA. 1985 Feb 22;253(8):1136-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         3968844
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Ann Intern Med. 1980 Jul;93(1):49-52
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         7396314
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Lancet. 1985 Feb 16;1(8425):381-3
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         2857430
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        BMJ. 1989 Aug 5;299(6695):367
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         2506971
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      10471598
     </pmid>
     <datecompleted>
      <year>
       1999
      </year>
      <month>
       10
      </month>
      <day>
       14
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2007
      </year>
      <month>
       11
      </month>
      <day>
       15
      </day>
     </daterevised>
     <article pubmodel="Print">
      <journal>
       <issn issntype="Print">
        1073-449X
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         160
        </volume>
        <issue>
         3
        </issue>
        <pubdate>
         <year>
          1999
         </year>
         <month>
          Sep
         </month>
        </pubdate>
       </journalissue>
       <title>
        American journal of respiratory and critical care medicine
       </title>
       <isoabbreviation>
        Am. J. Respir. Crit. Care Med.
       </isoabbreviation>
      </journal>
      <articletitle>
       Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease.
      </articletitle>
      <pagination>
       <medlinepgn>
        791-5
       </medlinepgn>
      </pagination>
      <abstract>
       <abstracttext>
        Respiratory syncytial virus (RSV) has been increasingly recognized as an important cause of serious respiratory illness in some adult populations, including those with underlying cardiopulmonary diseases. However, the precise incidence and the clinical impact of RSV in this group are unknown. Therefore, the incidence and clinical impact of RSV infection in persons with chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF) who reside in the community were prospectively evaluated over two consecutive winters in 134 persons. Eight RSV (incidence of 4.3 per 100 subject-winters), 13 influenza A (incidence of 7.0 per 100 subject-winters), seven rhinovirus, nine coronavirus, and two parainfluenza virus infections were identified. The clinical illnesses associated with RSV and influenza A virus were similar, causing both upper and lower respiratory signs and symptoms. The clinical impact was significant as three of eight RSV-infected subjects were hospitalized compared with six of 13 influenza A-infected persons and zero of seven rhinovirus-infected persons.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Walsh
        </lastname>
        <forename>
         E E
        </forename>
        <initials>
         EE
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medicine, Rochester General Hospital, Rochester, New York, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Falsey
        </lastname>
        <forename>
         A R
        </forename>
        <initials>
         AR
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Hennessey
        </lastname>
        <forename>
         P A
        </forename>
        <initials>
         PA
        </initials>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         AI-45248
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D013487">
        Research Support, U.S. Gov't, P.H.S.
       </publicationtype>
      </publicationtypelist>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Am J Respir Crit Care Med
      </medlineta>
      <nlmuniqueid>
       9421642
      </nlmuniqueid>
      <issnlinking>
       1073-449X
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      AIM
     </citationsubset>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000208">
        Acute Disease
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000328">
        Adult
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000368">
        Aged
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000369">
        Aged, 80 and over
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D002908">
        Chronic Disease
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D016001">
        Confidence Intervals
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D005260">
        Female
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006333">
        Heart Failure
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000150">
        complications
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015994">
        Incidence
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D009980">
        Influenza A virus
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D007251">
        Influenza, Human
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008173">
        Lung Diseases, Obstructive
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000150">
        complications
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008297">
        Male
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008875">
        Middle Aged
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018184">
        Paramyxoviridae Infections
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D010850">
        Picornaviridae Infections
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011446">
        Prospective Studies
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018357">
        Respiratory Syncytial Virus Infections
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000453">
        epidemiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012141">
        Respiratory Tract Infections
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000150">
        complications
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000453">
        epidemiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012621">
        Seasons
       </descriptorname>
      </meshheading>
     </meshheadinglist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        1999
       </year>
       <month>
        9
       </month>
       <day>
        3
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        1999
       </year>
       <month>
        9
       </month>
       <day>
        3
       </day>
       <hour>
        0
       </hour>
       <minute>
        1
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        1999
       </year>
       <month>
        9
       </month>
       <day>
        3
       </day>
       <hour>
        0
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       10471598
      </articleid>
      <articleid idtype="doi">
       10.1164/ajrccm.160.3.9901004
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
  </pubmedarticleset>
 </body>
</html>